|
Market Closed -
NYSE
00:01:44 06/10/2026 +04
|
After hours 01:02:00 | |||
| 265.76 USD | +1.12% |
|
263.83 | -0.73% |
| 01:11am | AbbVie Updates Q3, 2026 EPS Guidance to Include IPR&D Expense | MT |
| 11:51pm | Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer | MT |
| Market Cap | 464B 414B 386B 351B 662B 44,728B 666B 4,664B 1,815B 22,829B 1,743B 1,706B 73,379B | P/E 2026 * |
33.3x | P/E 2027 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 526B 469B 437B 398B 749B 50,660B 755B 5,283B 2,055B 25,856B 1,975B 1,932B 83,111B | EV / Sales 2026 * |
7.78x | EV / Sales 2027 * | 7.04x |
| Free-Float |
95.71% | Yield 2026 * |
2.64% | Yield 2027 * | 2.74% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
Tradegate
| 4AB | Real-time | |
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
Xetra
| 4AB | Delayed | |
|
London S.E.
| 0QCV | Delayed | |
|
CBOE
| Real-time | ||
|
Boerse Muenchen
| 4AB | Real-time | |
|
Börse Stuttgart
| 4AB | Delayed | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
CBOE
| 0QCV | Real-time | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed |
Last Transcript: AbbVie Inc.
| 1 day | +0.38% | ||
| 1 week | +0.54% | ||
| Current month | +1.59% | ||
| 1 month | +3.63% | ||
| 3 months | +1.80% | ||
| 6 months | +27.26% | ||
| Current year | +16.31% |
| 1 week | 257.87 |  | 268.93 |
| 1 month | 246.77 | | 269.39 |
| Current year | 190.75 | | 269.39 |
| 1 year | 190.75 | | 269.39 |
| 3 years | 135.85 | | 269.39 |
| 5 years | 106.86 | | 269.39 |
| 10 years | 55.06 | | 269.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Free | Director | 59 | 0.0000% | ||
| 30/09/26 | Free | Director | 129 | 0.0000% | ||
| 14/08/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| -0.78% | -2.45% | -34.86% | -61.12% | 166B | |
| Average | -0.77% | -3.36% | +19.44% | +46.25% | 386.29B | |
| Weighted average by Cap. | -0.55% | -3.46% | +25.78% | +64.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.6B 60.31B 56.18B 51.13B 96.29B 6,510B 97B 679B 264B 3,323B 254B 248B 10,681B | 73.5B 65.57B 61.08B 55.59B 105B 7,078B 105B 738B 287B 3,613B 276B 270B 11,612B |
| Net income | 14.07B 12.55B 11.69B 10.64B 20.04B 1,355B 20.18B 141B 54.96B 691B 52.81B 51.67B 2,223B | 19.05B 16.99B 15.83B 14.41B 27.13B 1,834B 27.33B 191B 74.42B 936B 71.5B 69.96B 3,009B |
| Net Debt | 61.59B 54.95B 51.19B 46.59B 87.73B 5,932B 88.38B 619B 241B 3,028B 231B 226B 9,732B | 53.09B 47.36B 44.13B 40.16B 75.62B 5,113B 76.18B 533B 207B 2,610B 199B 195B 8,388B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | $265.76 | +1.12% | 7,540,793 |
| 02/10/26 | $262.82 | +1.11% | 5,863,068 |
| 01/10/26 | $259.93 | -0.63% | 3,892,076 |
| 30/09/26 | $261.59 | -0.65% | 4,389,160 |
| 29/09/26 | $263.29 | -1.12% | 4,004,368 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
